Top Tweets for #Gi22
Twins ‘yan sila since the day they met nung 2024. 😆👯
@_ajyape @gianbernardino_
#G22 #G22_TheDissectionOfEve #Gian22 #Gi22
Day 2 @ASCO GI #GI22 presenting our research work on 1st line therapy for #GastricCancer with #Tisleluzumab demonstrating an improved overall survival for the anti-PD1 and better patient reported outcomes compared with chemotherapy. Thank you @BeiGeneGlobal for the opportunity to provide access to our patients in 🇵🇷
#GI24 @ASCO Ongoing Phase III STELLAR 303 of Zanzalintinib (XL-092) plus Atezolizumab in MSS chemorefractory #crcsm
>> building up on investigator initiated effort from CAMILLA CRC cohort presented @ #GI22 ✨✨
>> looking forward to interim results in the near future.
@OncoAlert
NETTER-2 establishes PRRT as 1L for many G2-3 NET pts (with low to moderate tumor burden?).
▶️Over time, those pts may have less SSTR expression/less efficacy of PRRT
▶️PRRT in late scenarium may not reproduce NETTER-2 results
⭐️NETTER-2 is my personal #GI22 star.
4/4
@ShaalanBeg @NiuSanford @ASCO @IbrahimSahinMD1 @fireflyann @DrKatePedersen @pashtoonkasi @ebludmir @manjuggm @gabe_a_brooks @oncology_bg @CathyEngMD @DrR_DUNNE @aparna1024 @GillSharlene @rachnatshroff @davisa20 @ronanhsieh @marklewismd @cancerassassin1 @YJanjigianMD @ARosen380 Need more button like shenanigans ala #GI22 https://t.co/8oyDWJ1mfW
So I decided to take the 'button' question and do a #gi22 'Person-on-the-street'
(People in this video may or may not have been pressured to say things.)
#forentertainmentonly
#notmedicaladvice
Day 3 #GI23 Highlights #CommunityOncology
1. #MOUNTAINEER: Tucat+Trast approved CRC
2. #SUNLIGHT: TAS102+Bev confirmed late option CRC
3. #E2211: Cape+Tem in pNET manuscript
4. #ctDNA kinetics CRC
5. TNT state in RectalCA
@ASCO #OncEd #MedEd @OncoAlert #GISM #MedTwitter
SPOTLIGHT trial - the addition of zolbetuximab to FOLFOX in 1L treatment of pts w/ CLDN18.2+/HER2- gastric/GEJ cancer results in:
⬆️PFS (10.6 vs 8.6 months, HR 0.75)
⬆️OS (18.2 vs 15.5 months, HR 0.75).
How to treat those pts - nivo or zolbe? Some thoughts🧵(1/10):
#GI22
🆕 🗞️#GI23 hasn’t started and we already have a very relevant #Tweetorial from the earlier oral presentation @ASCO #GI22 now published @NatureMedicine.
👇🏾The Galaxy 🌌 arm of the CIRCULATE 🇯🇵.
Rich data on a large cohort to learn from. ➡️Impact on ongoing trials.
#ctDNA🩸🧬
GALAXY arm from CIRCULATE-JAPAN just published in @NatureMedicine reporting #ctDNA #MRD and efficacy of adjuvant chemotherapy in patients with colorectal cancer with 18 month DFS. https://t.co/5sSRboGROt
a🧵
Expanded #ctDNA data from those presented at #GI22 @ASCO, more follow up showing the power of #ctDNA both prognostic and perhaps predictive (limited by observational nature of the study), to be assessed in CIRCULATE-US @NRGOncology GI-008 @adasarimd
In the observational arm of the CIRCULATE-Japan study, among patients with stage II-IV #ColorectalCancer, those with the presence of circulating #tumorDNA post-tumor resection have a high recurrence risk & are likely to benefit from adjuvant #chemotherapy
https://t.co/hKlRt1ZW6T
@BenWestphalen @AnnalsofSurgery @OncoAlert @UmbertoMalapel1 @ChristianRolfo #ctDNA not the only kind of #LiquidBiopsies. Other kinds of tumor trash🗑exist in🩸including #CTCs🟣.
Excellent work @AnnalsofSurgery by my medical school @AKUGlobal alumni @ammar_asrar & neighbor at @nyulangone🗽.
👀@gregorybotta & our group @JCO_ASCO on #ctDNA #GI22👇🏾 #PANCSM
I assume this filing is for full 2L liver cancer approval, based on KN-394 (OS data at #GI22). Keytruda has 2L accelerated approval here, but got a CRL for 1L liver cancer $MRK
Delighted to work with @sepideh_gholami @MayCho_MD @AnwaarSaeed3 to summarize the impactful studies of @ASCO #GI22 @OHSUsurgery @OHSUKnight @UCD_Cancer @KUcancercenter @UCIAntiCancer https://t.co/XDKgmCdXJy
Released from #GI22 a video created with @PeerViewInstitute: "Embracing the Era of Individualized Therapy in Advanced Biliary Cancers," featuring Milind Javle, MD, Mitesh J. Borad, MD, Aiwu Ruth He, MD, PhD, & Flavio G. Rocha, MD, FACS, FSSO. Download now https://t.co/rVEk9Ml80Z
Check out this video from @PeerView and #curecc to hear the latest new and emerging strategies of how biomarker-guided treatments and immunotherapy are changing practice in advanced #BiliaryCancers. https://t.co/rVEk9Ml80Z #Cholangiocarcinoma #GI22 #MedEd @JavleMilind @Ruthhe12
Watch this expert-led video created with @PeerView on using targeted agents & immunotherapy in patients w/advanced disease: Embracing the Era of Individualized Treatment of #BiliaryCancers ft. Drs. Javle (@JavleMilind), He (@Ruthhe12), Borad, & Rocha #GI22 https://t.co/rVEk9Ml80Z
Join us for a free webinar on June 29 to guide physicians in #LMICs in putting the latest #ASCO22 #GIcancer science & evidence into practice.
📅 Register: https://t.co/aWDQkPmuRZ #gicsm #GI22 @JCOGO_ASCO #GlobalOncology #globonc
Hear from Dr. Javle (@JavleMilind), Dr. He (@Ruthhe12), Dr. Borad, & Dr. Rocha on individualizing patient care with biomarker-guided treatments and immunotherapy and have a look at the future of precision medicine in #BiliaryCancers https://t.co/rVEk9Ml80Z #GI22 @PeerView #MedEd
Check out this video from @PeerView and @curecc to hear the latest new and emerging strategies of how biomarker-guided treatments and immunotherapy are changing practice in advanced #BiliaryCancers.
https://t.co/rVEk9M3x9r #Cholangiocarcinoma #GI22 #MedEd @JavleMilind @RuthHe12
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers